Home
    Disclaimer

    Salvia divinorum Stats & Data

    Sally Sally d Magic mint Seer's sage Diviner's sage
    Psychoactive Class Psychedelic

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Smoked (Dried Leaf)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Smoked (5X Extract)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Smoked (10X Extract)
    0-1 minutes
    4-19 minutes
    10-30 minutes
    15 minutes - 1.0 hours
    Sublingual/Quid (Fresh Leaf)
    10-19 minutes
    30 minutes - 1.0 hours
    30 minutes - 1.5 hours
    1-2 hours
    Sublingual/Quid (Dried Leaf)
    10-19 minutes
    30 minutes - 1.0 hours
    30 minutes - 1.5 hours
    1-2 hours
    Vaporized (Pure Salvinorin A)
    0-1 minutes
    1-10 minutes
    10-19 minutes
    15 minutes - 1.0 hours

    Empirical Duration

    Erowid Reports
    Onset Come Up Peak Offset
    Smoked (175 reports)

    Community Effects

    TripSit
    Positive
    euphoria visual enhancement mood lift dissociation
    Negative
    addiction

    Experience Report Analysis

    Erowid BlueLight
    2,197 Reports
    1995–2025 Date Range
    503 With Age Data
    31 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid + Bluelight

    Effects aggregated from 2,247 experience reports (2,197 Erowid + 372 Bluelight)

    2,247 Reports
    139 Effects Detected
    42 Positive
    62 Adverse
    35 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 42

    Color Enhancement 32.7% 83%
    Awe 30.0% 83%
    Music Enhancement 28.1% 70%
    Geometric Imagery 28.0% 88%
    Tactile Enhancement 26.2% 85%
    Empathy 22.0% 85%
    Stimulation 20.0% 76%
    Euphoria 19.6% 87%
    Focus Enhancement 18.5% 70%
    Introspection 16.3% 82%
    Insight 12.0% 83%
    Mystical Quality 10.0% 87%
    Joy 10.0% 87%
    Wonder 10.0% 83%
    Body High 9.1% 84%
    Fractal Imagery 8.0% 89%
    Contentment 8.0% 80%
    Peace 8.0% 88%
    Visual Trails 6.0% 82%
    Bliss 6.0% 85%

    Adverse Effects 62

    Fear 62.0% 89%
    Anxiety 51.9% 84%
    Thought Disorganization 50.0% 81%
    Depersonalization 48.0% 84%
    Body Load 38.0% 77%
    Confusion 37.0% 87%
    Entity Imagery 32.0% 87%
    Panic 30.0% 89%
    Scene Replacement 20.0% 90%
    Environmental Transfiguration 18.0% 85%
    Body Distortion 18.0% 90%
    Memory Suppression 16.3% 81%
    Temporal Disorientation 16.0% 85%
    Derealization 12.0% 88%
    Ataxia 10.0% 78%
    Heaviness 10.0% 81%
    Time Looping 10.0% 88%
    Delusion 10.0% 85%
    Motor Impairment 8.1% 79%
    Sweating 8.0% 82%

    Dose-Response Correlation

    How effect frequency changes across dose levels

    View data table
    Effect Threshold (n=381)
    Anxiety 53.5%
    Visual Distortions 50.9%
    Confusion 42.0%
    Color Enhancement 31.5%
    Music Enhancement 28.9%
    Tactile Enhancement 27.6%
    Closed-Eye Visuals 25.7%
    Empathy 24.4%
    Dissociation 22.8%
    Auditory Effects 22.8%
    Euphoria 22.6%
    Focus Enhancement 19.7%
    Stimulation 18.6%
    Introspection 18.6%
    Memory Suppression 17.6%

    Subjective Effect Ontology

    Experience Reports

    Structured effect tags extracted from 2,569 Erowid & Bluelight experience reports using a controlled vocabulary of 220+ canonical effects across 15 domains.

    Auditory

    music enhancement 617 28.1% auditory effects 496 19.8%

    Cognitive

    confusion 831 36.4% focus enhancement 406 18.5% introspection 367 17.0% memory suppression 366 17.7%

    Emotional

    anxiety 1167 50.9% empathy 495 19.5% euphoria 441 18.7%

    Motor

    stimulation 450 18.5% sedation 194 8.3% motor impairment 183 11.6%

    Selfhood

    dissociation 508 21.0% ego dissolution 201 12.6%

    Somatic

    body high 204 8.9% sweating 180 8.0%

    Tactile

    tactile enhancement 588 23.1%

    Temporal

    time distortion 238 10.0%

    Visual

    visual distortions 1022 41.5% color enhancement 735 30.6% closed eye visuals 506 23.2% open eye visuals 255 11.2%

    22 unique effects extracted · Derived from Erowid & Bluelight reports

    Dose–Effect Mapping

    Experience Reports

    How reported effects shift across dose tiers, based on 2197 experience reports.

    Limited tier coverage — most reports fall within the Threshold range. Effects at other dose levels may not be represented.

    Effect Threshold (n=381)
    anxiety
    54%
    visual distortions
    51%
    confusion
    42%
    color enhancement
    32%
    music enhancement
    29%
    tactile enhancement
    28%
    closed-eye visuals
    26%
    empathy
    24%
    dissociation
    23%
    auditory effects
    23%
    euphoria
    23%
    focus enhancement
    20%
    stimulation
    19%
    introspection
    19%
    memory suppression
    18%
    open-eye visuals
    12%
    time distortion
    11%
    sweating
    10%
    body high
    10%
    motor impairment
    9%

    Showing top 20 of 34 effects

    Dosage Distribution

    Dose distribution from experience reports

    Median: 200.0 mg IQR: 100.0–400.0 mg n=378

    Real-World Dose Distribution

    62K Doses

    From 2294 individual dose entries

    Sublingual (n=39)

    Median: 2000.0mg 25th: 250.0mg 75th: 4425.0mg 90th: 6800.0mg
    mg/kg median: 39.193 mg/kg 75th: 83.0

    Smoked (n=501)

    Median: 166.0mg 25th: 100.0mg 75th: 330.0mg 90th: 500.0mg
    mg/kg median: 2.45 mg/kg 75th: 5.125

    Oral (n=7)

    Median: 1000.0mg 25th: 500.0mg 75th: 1750.0mg 90th: 5500.0mg
    mg/kg median: 15.204 mg/kg 75th: 23.322

    Common Combinations

    Most co-occurring substances in experience reports

    Form / Preparation

    Most common forms and preparations reported

    Body-Weight Dosing

    Dose relative to body weight from reports with weight data

    Smoked

    Median: 2.594 mg/kg IQR: 1.297–5.513 mg/kg n=363

    Oral

    Median: 15.198 mg/kg IQR: 7.353–29.002 mg/kg n=8

    Unknown

    Median: 62.972 mg/kg IQR: 33.389–133.333 mg/kg n=17

    Sublingual

    Median: 0.053 mg/kg IQR: 0.027–24.958 mg/kg n=15

    Redose Patterns

    Redosing behavior across 2027 reports

    9.9% Redosed
    1.1 Avg Doses
    14m Median Interval
    ← Back to Salvia divinorum